Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126930691 | 12693069 | 1 | I | 20090910 | 20151204 | 20160829 | 20160829 | EXP | GB-ROCHE-1821820 | ROCHE | 70.00 | YR | M | Y | 0.00000 | 20160829 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126930691 | 12693069 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 20896 | ||||||||||
126930691 | 12693069 | 2 | SS | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
126930691 | 12693069 | 3 | SS | LEUKINE | SARGRAMOSTIM | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126930691 | 12693069 | 1 | Pancreatic carcinoma |
126930691 | 12693069 | 2 | Pancreatic carcinoma |
126930691 | 12693069 | 3 | Pancreatic carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126930691 | 12693069 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126930691 | 12693069 | Abdominal pain | |
126930691 | 12693069 | Escherichia sepsis | |
126930691 | 12693069 | Hepatic function abnormal | |
126930691 | 12693069 | Lethargy | |
126930691 | 12693069 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |